Ansfield v. Omnicare, Inc.

KBC Asset Management sued Omnicare (a pharmaceutical company) and affiliated individuals, on behalf of Ansfield and other similarly situated shareholders, alleging that the defendants had committed securities fraud in violation of the Securities Exchange Act of 1934, 15 U.S.C. 78j(b) and 78t(a), and Securities and Exchange Commission (SEC) Rule 10b-5. KBC charged the defendants with making various material misrepresentations and omissions between January 10, 2007 and August 5, 2010 in public and in SEC filings regarding Omnicare’s compliance with Medicare and Medicaid regulations. The district court dismissed. The Sixth Circuit affirmed, based on the Private Securities Litigation Reform Act of 1995, 15 U.S.C. 78u-4, which created heightened pleading standards for securities-fraud cases and requires that plaintiffs identify each misleading or false statement and explain how it is misleading. Plaintiffs also must “state with particularity facts giving rise to a strong inference that the defendant[s] acted with the required state of mind.” KCB did not meet those requirements. View "Ansfield v. Omnicare, Inc." on Justia Law